Metraipolis › archive › dc_00dc702237c8

Does tumor-infiltrating lymphocyte therapy improve survival outcomes in patients with advanced melanoma? — Europe PMC PMID:41716797

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41716797
DOI
10.3389/fmed.2026.1775031
License (as archived)
solo-consultazione
Archived
2026-11-06T03:06:50.037Z
SHA-256 of the archived text
ce8de0a72622a0d9a93245f205590e7c83aa07967f74ed46636ee159ae908969
Stable URL of this page
https://metraipolis.com/documento/dc_00dc702237c8

How to cite

Does tumor-infiltrating lymphocyte therapy improve survival outcomes in patients with advanced melanoma? — Europe PMC PMID:41716797 — Europe PMC (en), https://europepmc.org/article/MED/41716797 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_00dc702237c8 (Metraipolis archive dc_00dc702237c8, sha256 ce8de0a72622a0d9a93245f205590e7c83aa07967f74ed46636ee159ae908969)
BibTeX
@misc{dc00dc702237c8,
  title = {Does tumor-infiltrating lymphocyte therapy improve survival outcomes in patients with advanced melanoma? — Europe PMC PMID:41716797},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41716797},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_00dc702237c8; sha256 ce8de0a72622a0d9a93245f205590e7c83aa07967f74ed46636ee159ae908969},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41716797. Agents can read the archived copy with the MCP tool read_document.